We are live on !
Find out more
Exane Derivatives Portfolio holdings
AUM
$174M
Turnover
34.02%
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$181M
(-51%)
Cap. Flow
-$142M
Cap. Flow % of AUM
Cap. Flow %
-81.48%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
1,070
New
55
Increased
89
Reduced
355
Closed
309
Avg Time Held
Equity + Options
2.5
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$4.55M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$3.23M |
| 3 |
Dow Inc
DOW
|
+$1.28M |
| 4 |
Conagra Brands
CAG
|
+$1.04M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$952K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.98M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.74M |
| 3 |
Visa
V
|
+$4.62M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$4.31M |
| 5 |
Stellantis
STLA
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.4% |
| 2 | Technology | 15.03% |
| 3 | Healthcare | 12.1% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
GreenTree Hospitality
GHG
$94.9M
| $112K | 0.06% |
26,852
| – | – |
2020 Q4
6 quarters
|
|
252
SouthState Bank Corp
SSB
$10.2B
| $111K | 0.06% |
1,444
+42
| +3% | +$3.27K |
2022 Q1
1 quarter
|
|
253
Newmont
NEM
$111B
| $111K | 0.06% |
1,857
-6,324
| -77% | -$447K |
2019 Q1
13 quarters
|
|
254
DELISTED
Heritage Commerce
HTBK
| $110K | 0.06% |
10,338
| – | – |
2021 Q2
4 quarters
|
|
255
Fiverr
FVRR
$302M
| $108K | 0.06% |
3,143
| – | – |
2020 Q4
6 quarters
|
|
256
Herc Holdings
HRI
$5.55B
| $108K | 0.06% |
1,197
-810
| -40% | -$97.3K |
2020 Q3
7 quarters
|
|
257
Origin Bancorp
OBK
$1.62B
| $108K | 0.06% |
2,776
+77
| +3% | +$3.03K |
2022 Q1
1 quarter
|
|
258
IQVIA
IQV
$44.1B
| $106K | 0.06% |
490
| – | – |
2018 Q3
15 quarters
|
|
259
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$291M
| $106K | 0.06% |
2,775
| – | – |
2017 Q2
20 quarters
|
|
260
Neurocrine Biosciences
NBIX
$14.9B
| $106K | 0.06% |
1,084
+1,081
| +36,033% | +$100K |
2017 Q3
19 quarters
|
|
261
NIO
NIO
$8.04B
| $103K | 0.06% |
4,724
-5,957
| -56% | -$109K |
2020 Q1
9 quarters
|
|
262
Raymond James Financial
RJF
$30.2B
| $101K | 0.06% |
1,130
-1,517
| -57% | -$149K |
2021 Q2
4 quarters
|
|
263
MSCI
MSCI
$45.3B
| $100K | 0.06% |
242
-413
| -63% | -$180K |
2020 Q4
6 quarters
|
|
264
NetEase
NTES
$72.8B
| $100K | 0.06% |
1,067
-3,760
| -78% | -$358K |
2021 Q1
5 quarters
|
|
265
Lockheed Martin
LMT
$147B
| $98.9K | 0.06% |
230
+1
| +0.4% | +$439 |
2015 Q3
27 quarters
|
|
266
Freeport-McMoran
FCX
$89.7B
| $97.6K | 0.06% |
3,337
-38,521
| -92% | -$1.54M |
2019 Q4
10 quarters
|
|
267
Merchants Bancorp
MBIN
$2.39B
| $96.2K | 0.06% |
4,246
+90
| +2% | +$2.2K |
2022 Q1
1 quarter
|
|
268
DELISTED
Comerica
CMA
| $96K | 0.06% |
1,309
-205
| -14% | -$16.6K |
2021 Q1
5 quarters
|
|
269
Phathom Pharmaceuticals
PHAT
$467M
| $94K | 0.05% |
11,141
+5,267
| +90% | +$54.2K |
2020 Q1
9 quarters
|
|
270
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $93.6K | 0.05% |
740
| – | – |
2021 Q4
2 quarters
|
|
271
Kiniksa Pharmaceuticals
KNSA
$7.25B
| $92K | 0.05% |
9,496
| – | – |
2020 Q1
9 quarters
|
|
272
Pathward Financial
CASH
$1.56B
| $88.1K | 0.05% |
2,279
-267
| -10% | -$11.4K |
2021 Q2
4 quarters
|
|
273
Axsome Therapeutics
AXSM
$7.57B
| $87.3K | 0.05% |
2,279
+2,249
| +7,497% | +$71.1K |
2020 Q1
9 quarters
|
|
274
Aurinia Pharmaceuticals
AUPH
$2.23B
| $87.2K | 0.05% |
8,683
| – | – |
2020 Q2
8 quarters
|
|
275
Charter Communications
CHTR
$12.8B
| $86.7K | 0.05% |
185
-5
| -3% | -$2.44K |
2019 Q4
10 quarters
|
|
Similar funds
GDWAM
Exane Derivatives's Q2 2022 Portfolio in Review
As of Q2 2022, Exane Derivatives held 1,070 positions worth $174M, down 51% from $355M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Exane Derivatives withdrew a net $142M in Q2 2022, closing 309 positions and reducing 355 holdings. Its most notable exit was Amazon, an estimated $5.98M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Exane Derivatives opened a new position in iShares Core US Aggregate Bond ETF worth $4.5M.
- Exane Derivatives's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 44,298 shares worth $4.5M.
- Exane Derivatives added most to Dow Inc in Q2 2022, an estimated $1.28M increase.
- Exane Derivatives's biggest Q2 2022 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $4.74M.
- Exane Derivatives fully exited Amazon in Q2 2022, selling an estimated $5.98M.
- Exane Derivatives's ten largest holdings make up 28% of its $174M portfolio in Q2 2022.
- Exane Derivatives opened 55 new positions and closed 309 in Q2 2022.
- Exane Derivatives's portfolio value fell 51% quarter-over-quarter to $174M.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.